A Randomized, Double-blind, Placebo-controlled, Parallel Group Clinical Study to Assess the Safety and Efficacy of Three Doses of Clobetasol Propionate when Administered Intra-orally Twice Daily in Patients with Oral Lichen Planus (OLP) using Rivelin®-CLO patches
Phase of Trial: Phase II
Latest Information Update: 21 Dec 2018
At a glance
- Drugs Clobetasol (Primary)
- Indications Lichen planus
- Focus Therapeutic Use
- Sponsors AFYX Therapeutics
- 23 Jul 2018 According to a Dermtreat media release, first patient has been dosed, and results are expected in the first half of 2019.
- 23 Jul 2018 Status changed from not yet recruiting to recruiting.
- 09 Jul 2018 Status changed from planning to not yet recruiting.